Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tokuyama Sekisui Co. Ltd. has 1 pending office action in Biotechnology & Pharmaceuticals. The action is handled by a single examiner in a single art unit, creating a concentrated prosecution profile.
GU, QINHUA is the identified examiner. Counsel can direct its preparation toward that examiner’s record and the applicable biotechnology examination setting.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GU, QINHUA | 1 | 76.2% | +27.1% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17907866 | STORAGE CONTAINER FOR CELL-CONTAINING SOLUTION AND STORAGE SOLUTION | GU, QINHUA | — |
| Art Unit | Apps |
|---|---|
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17907866 | STORAGE CONTAINER FOR CELL-CONTAINING SOLUTION AND STORAGE SOLUTION | GU, QINHUA | 1633 | §103 | Non-Final OA | — | Pending | Aug 29, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTokuyama Sekisui Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Qinhua Gu has the most, with 1 of Tokuyama Sekisui Co. Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
